{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:43:16Z","timestamp":1792788196812,"version":"4.5.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T00:00:00Z","timestamp":1741824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T00:00:00Z","timestamp":1741824000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Ningbo Major Research and Development Plan Project","award":["2023Z196"],"award-info":[{"award-number":["2023Z196"]}]},{"name":"Ningbo Major Research and Development Plan Project","award":["2023Z173"],"award-info":[{"award-number":["2023Z173"]}]},{"name":"Ningbo Medical and Health Brand Discipline","award":["PPXK2024-01"],"award-info":[{"award-number":["PPXK2024-01"]}]},{"DOI":"10.13039\/501100017531","name":"Medical and Health Research Project of Zhejiang Province","doi-asserted-by":"publisher","award":["2024KY303"],"award-info":[{"award-number":["2024KY303"]}],"id":[{"id":"10.13039\/501100017531","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["31800903"],"award-info":[{"award-number":["31800903"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"PhD start-up funding of LiHuiLi hospital","award":["2024BSKY-ZW"],"award-info":[{"award-number":["2024BSKY-ZW"]}]},{"name":"the Natural Science Foundation of Zhejiang Province","award":["LMS25H090008"],"award-info":[{"award-number":["LMS25H090008"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"DOI":"10.1186\/s12974-025-03407-5","type":"journal-article","created":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T11:38:26Z","timestamp":1741865906000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Target inhibition of SPAK in choroid plexus attenuates T cell infiltration and demyelination in experimental autoimmune encephalomyelitis"],"prefix":"10.1186","volume":"22","author":[{"given":"Chenxing","family":"Qi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuhang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junxiao","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiming","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guomin","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shujun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuyin","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongyue","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wu","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,13]]},"reference":[{"issue":"6","key":"3407_CR1","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1172\/JCI21357","volume":"113","author":"DA Hafler","year":"2004","unstructured":"Hafler DA. Multiple sclerosis. J Clin Invest. 2004;113(6):788.","journal-title":"J Clin Invest"},{"issue":"7631","key":"3407_CR2","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1038\/540S1a","volume":"540","author":"B Owens","year":"2016","unstructured":"Owens B. Multiple sclerosis. Nature. 2016;540(7631):S1.","journal-title":"Nature"},{"issue":"20","key":"3407_CR3","first-page":"2078","volume":"328","author":"R Marcus","year":"2022","unstructured":"Marcus R, What. Is Multiple Sclerosis? JAMA. 2022;328(20):2078.","journal-title":"Is Multiple Sclerosis? JAMA"},{"issue":"12","key":"3407_CR4","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1007\/s40263-022-00965-7","volume":"36","author":"L Freeman","year":"2022","unstructured":"Freeman L, Longbrake EE, Coyle PK, Hendin B, Vollmer T. High-Efficacy therapies for Treatment-Naive individuals with Relapsing-Remitting multiple sclerosis. CNS Drugs. 2022;36(12):1285.","journal-title":"CNS Drugs"},{"issue":"3","key":"3407_CR5","first-page":"160","volume":"19","author":"K Bjornevik","year":"2023","unstructured":"Bjornevik K, Munz C, Cohen JI, Ascherio A. Epstein-Barr virus as a leading cause of multiple sclerosis: mechanisms and implications. Nat Rev Neurol. 2023;19(3):160.","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"3407_CR6","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/s41582-020-00427-y","volume":"17","author":"I Cortese","year":"2021","unstructured":"Cortese I, Reich DS, Nath A. Progressive multifocal leukoencephalopathy and the spectrum of JC virus-related disease. Nat Rev Neurol. 2021;17(1):37.","journal-title":"Nat Rev Neurol"},{"issue":"2","key":"3407_CR7","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/S1474-4422(14)70256-X","volume":"14","author":"DH Mahad","year":"2015","unstructured":"Mahad DH, Trapp BD, Lassmann H. Pathological mechanisms in progressive multiple sclerosis. Lancet Neurol. 2015;14(2):183.","journal-title":"Lancet Neurol"},{"issue":"Pt 11","key":"3407_CR8","doi-asserted-by":"publisher","first-page":"3427","DOI":"10.1093\/brain\/awt259","volume":"136","author":"G Kunis","year":"2013","unstructured":"Kunis G, Baruch K, Rosenzweig N, Kertser A, Miller O, Berkutzki T, et al. IFN-gamma-dependent activation of the brain\u2019s choroid plexus for CNS immune surveillance and repair. Brain. 2013;136(Pt 11):3427.","journal-title":"Brain"},{"issue":"5","key":"3407_CR9","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1038\/ni.1716","volume":"10","author":"A Reboldi","year":"2009","unstructured":"Reboldi A, Coisne C, Baumjohann D, Benvenuto F, Bottinelli D, Lira S, et al. C-C chemokine receptor 6-regulated entry of TH-17 cells into the CNS through the choroid plexus is required for the initiation of EAE. Nat Immunol. 2009;10(5):514.","journal-title":"Nat Immunol"},{"issue":"1","key":"3407_CR10","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s12974-022-02415-z","volume":"19","author":"W Zheng","year":"2022","unstructured":"Zheng W, Feng Y, Zeng Z, Ye M, Wang M, Liu X, et al. Choroid plexus-selective inactivation of adenosine A(2A) receptors protects against T cell infiltration and experimental autoimmune encephalomyelitis. J Neuroinflammation. 2022;19(1):52.","journal-title":"J Neuroinflammation"},{"issue":"4","key":"3407_CR11","doi-asserted-by":"publisher","first-page":"e22833","DOI":"10.1096\/fj.202201767R","volume":"37","author":"Y Zheng","year":"2023","unstructured":"Zheng Y, Hu L, Yang Y, Zheng C, Tu W, Lin H, et al. Blocking the IFN-gamma signal in the choroid plexus confers resistance to experimental autoimmune encephalomyelitis. FASEB J. 2023;37(4):e22833.","journal-title":"FASEB J"},{"issue":"4","key":"3407_CR12","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/j.cell.2023.01.017","volume":"186","author":"SM Robert","year":"2023","unstructured":"Robert SM, Reeves BC, Kiziltug E, Duy PQ, Karimy JK, Mansuri MS, et al. The choroid plexus links innate immunity to CSF dysregulation in hydrocephalus. Cell. 2023;186(4):764.","journal-title":"Cell"},{"issue":"8","key":"3407_CR13","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1038\/nm.4361","volume":"23","author":"JK Karimy","year":"2017","unstructured":"Karimy JK, Zhang J, Kurland DB, Theriault BC, Duran D, Stokum JA, et al. Inflammation-dependent cerebrospinal fluid hypersecretion by the choroid plexus epithelium in posthemorrhagic hydrocephalus. Nat Med. 2017;23(8):997.","journal-title":"Nat Med"},{"issue":"1","key":"3407_CR14","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s12974-022-02456-4","volume":"19","author":"J Wang","year":"2022","unstructured":"Wang J, Liu R, Hasan MN, Fischer S, Chen Y, Como M, et al. Role of SPAK-NKCC1 signaling cascade in the choroid plexus blood-CSF barrier damage after stroke. J Neuroinflammation. 2022;19(1):91.","journal-title":"J Neuroinflammation"},{"issue":"3","key":"3407_CR15","doi-asserted-by":"publisher","first-page":"e14654","DOI":"10.1111\/cns.14654","volume":"30","author":"MIH Bhuiyan","year":"2024","unstructured":"Bhuiyan MIH, Habib K, Sultan MT, Chen F, Jahan I, Weng Z, et al. SPAK inhibitor ZT-1a attenuates reactive astrogliosis and oligodendrocyte degeneration in a mouse model of vascular dementia. CNS Neurosci Ther. 2024;30(3):e14654.","journal-title":"CNS Neurosci Ther"},{"issue":"766","key":"3407_CR16","doi-asserted-by":"publisher","first-page":"eadn7095","DOI":"10.1126\/scitranslmed.adn7095","volume":"16","author":"Q Li","year":"2024","unstructured":"Li Q, Sandoval A, Moth J, Shang J, Liew JY, Dunn T, et al. Reduction of prolonged excitatory neuron swelling after spinal cord injury improves locomotor recovery in mice. Sci Transl Med. 2024;16(766):eadn7095.","journal-title":"Sci Transl Med"},{"key":"3407_CR17","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.pnpbp.2015.03.007","volume":"61","author":"SS Yang","year":"2015","unstructured":"Yang SS, Huang CL, Chen HE, Tung CS, Shih HP, Liu YP. Effects of SPAK knockout on sensorimotor Gating, novelty exploration, and brain area-dependent expressions of NKCC1 and KCC2 in a mouse model of schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 2015;61:30.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"9","key":"3407_CR18","doi-asserted-by":"publisher","first-page":"e74614","DOI":"10.1371\/journal.pone.0074614","volume":"8","author":"L Yang","year":"2013","unstructured":"Yang L, Cai X, Zhou J, Chen S, Chen Y, Chen Z, et al. STE20\/SPS1-related proline\/alanine-rich kinase is involved in plasticity of GABA signaling function in a mouse model of acquired epilepsy. PLoS ONE. 2013;8(9):e74614.","journal-title":"PLoS ONE"},{"issue":"8","key":"3407_CR19","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1177\/13524585241238094","volume":"30","author":"E Levit","year":"2024","unstructured":"Levit E, Ren Z, Gonzenbach V, Azevedo CJ, Calabresi PA, Cree BA, et al. Choroid plexus volume differentiates MS from its mimics. Mult Scler. 2024;30(8):1072.","journal-title":"Mult Scler"},{"key":"3407_CR20","doi-asserted-by":"crossref","unstructured":"Jankowska A, Chwojnicki K, Grzywinska M, Trzonkowski P, Szurowska E. Choroid plexus volume Change-A candidate for a new radiological marker of MS progression. Diagnostics (Basel). 2023;13(16).","DOI":"10.3390\/diagnostics13162668"},{"key":"3407_CR21","doi-asserted-by":"crossref","unstructured":"Muller J, Sinnecker T, Wendebourg MJ, Schlager R, Kuhle J, Schadelin S et al. Choroid plexus volume in multiple sclerosis vs neuromyelitis Optica spectrum disorder: A retrospective, Cross-sectional analysis. Neurol Neuroimmunol Neuroinflamm. 2022;9(3).","DOI":"10.1212\/NXI.0000000000001147"},{"issue":"8","key":"3407_CR22","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.molmed.2015.05.008","volume":"21","author":"KT Kahle","year":"2015","unstructured":"Kahle KT, Khanna AR, Alper SL, Adragna NC, Lauf PK, Sun D, et al. K-Cl cotransporters, cell volume homeostasis, and neurological disease. Trends Mol Med. 2015;21(8):513.","journal-title":"Trends Mol Med"},{"issue":"12","key":"3407_CR23","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1096\/fj.04-2030fje","volume":"19","author":"A Weaver","year":"2005","unstructured":"Weaver A, Goncalves da Silva A, Nuttall RK, Edwards DR, Shapiro SD, Rivest S, et al. An elevated matrix metalloproteinase (MMP) in an animal model of multiple sclerosis is protective by affecting Th1\/Th2 polarization. FASEB J. 2005;19(12):1668.","journal-title":"FASEB J"},{"issue":"3","key":"3407_CR24","doi-asserted-by":"publisher","first-page":"626","DOI":"10.14336\/AD.2018.0928","volume":"10","author":"H Huang","year":"2019","unstructured":"Huang H, Song S, Banerjee S, Jiang T, Zhang J, Kahle KT, et al. The WNK-SPAK\/OSR1 kinases and the Cation-Chloride cotransporters as therapeutic targets for neurological diseases. Aging Dis. 2019;10(3):626.","journal-title":"Aging Dis"},{"issue":"5","key":"3407_CR25","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1038\/sj.emboj.7600125","volume":"23","author":"Y Li","year":"2004","unstructured":"Li Y, Hu J, Vita R, Sun B, Tabata H, Altman A. SPAK kinase is a substrate and target of PKCtheta in T-cell receptor-induced AP-1 activation pathway. EMBO J. 2004;23(5):1112.","journal-title":"EMBO J"},{"issue":"4","key":"3407_CR26","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.2353\/ajpath.2008.080339","volume":"173","author":"Y Yan","year":"2008","unstructured":"Yan Y, Dalmasso G, Nguyen HT, Obertone TS, Charrier-Hisamuddin L, Sitaraman SV, et al. Nuclear factor-kappaB is a critical mediator of Ste20-like proline-\/alanine-rich kinase regulation in intestinal inflammation. Am J Pathol. 2008;173(4):1013.","journal-title":"Am J Pathol"},{"issue":"4","key":"3407_CR27","first-page":"266","volume":"32","author":"K Duval","year":"2017","unstructured":"Duval K, Grover H, Han LH, Mou Y, Pegoraro AF, Fredberg J, et al. Modeling physiological events in 2D vs. 3D cell culture. Physiol (Bethesda). 2017;32(4):266.","journal-title":"Physiol (Bethesda)"},{"issue":"13","key":"3407_CR28","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1177\/1352458517726592","volume":"23","author":"F Sellebjerg","year":"2017","unstructured":"Sellebjerg F, Bornsen L, Ammitzboll C, Nielsen JE, Vinther-Jensen T, Hjermind LE, et al. Defining active progressive multiple sclerosis. Mult Scler. 2017;23(13):1727.","journal-title":"Mult Scler"},{"issue":"4","key":"3407_CR29","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1002\/ana.1218","volume":"50","author":"Y Galboiz","year":"2001","unstructured":"Galboiz Y, Shapiro S, Lahat N, Rawashdeh H, Miller A. Matrix metalloproteinases and their tissue inhibitors as markers of disease subtype and response to interferon-beta therapy in relapsing and secondary-progressive multiple sclerosis patients. Ann Neurol. 2001;50(4):443.","journal-title":"Ann Neurol"},{"issue":"12","key":"3407_CR30","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.1002\/jnr.25249","volume":"101","author":"B Saatian","year":"2023","unstructured":"Saatian B, Deshpande K, Herrera R, Sedighi S, Eisenbarth R, Iyer M, et al. Breast-to-brain metastasis is exacerbated with chemotherapy through blood-cerebrospinal fluid barrier and induces Alzheimer\u2019s-like pathology. J Neurosci Res. 2023;101(12):1900.","journal-title":"J Neurosci Res"},{"key":"3407_CR31","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1476-4598-13-18","volume":"13","author":"Q Huang","year":"2014","unstructured":"Huang Q, Lan F, Wang X, Yu Y, Ouyang X, Zheng F, et al. IL-1beta-induced activation of p38 promotes metastasis in gastric adenocarcinoma via upregulation of AP-1\/c-fos, MMP2 and MMP9. Mol Cancer. 2014;13:18.","journal-title":"Mol Cancer"},{"issue":"2","key":"3407_CR32","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s00592-018-1237-5","volume":"56","author":"FK Tombulturk","year":"2019","unstructured":"Tombulturk FK, Soydas T, Sarac EY, Tuncdemir M, Coskunpinar E, Polat E, et al. Regulation of MMP 2 and MMP 9 expressions modulated by AP-1 (c-jun) in wound healing: improving role of Lucilia sericata in diabetic rats. Acta Diabetol. 2019;56(2):177.","journal-title":"Acta Diabetol"},{"issue":"5","key":"3407_CR33","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1161\/STROKEAHA.121.038351","volume":"53","author":"MIH Bhuiyan","year":"2022","unstructured":"Bhuiyan MIH, Young CB, Jahan I, Hasan MN, Fischer S, Meor Azlan NF, et al. NF-kappaB Signaling-Mediated activation of WNK-SPAK-NKCC1 cascade in worsened stroke outcomes of Ang II-Hypertensive mice. Stroke. 2022;53(5):1720.","journal-title":"Stroke"},{"issue":"Pt 20","key":"3407_CR34","doi-asserted-by":"publisher","first-page":"3293","DOI":"10.1242\/jcs.029223","volume":"121","author":"C Richardson","year":"2008","unstructured":"Richardson C, Alessi DR. The regulation of salt transport and blood pressure by the WNK-SPAK\/OSR1 signalling pathway. J Cell Sci. 2008;121(Pt 20):3293.","journal-title":"J Cell Sci"},{"key":"3407_CR35","doi-asserted-by":"crossref","unstructured":"Gong Y, Wu M, Gao F, Shi M, Gu H, Gao R et al. Inhibition of the p\u2013SPAK\/p\u2013NKCC1 signaling pathway protects the blood\u2013brain barrier and reduces neuronal apoptosis in a rat model of surgical brain injury. Mol Med Rep. 2021;24(4).","DOI":"10.3892\/mmr.2021.12356"},{"key":"3407_CR36","doi-asserted-by":"crossref","unstructured":"Zhang Z, Wang H, Tao B, Shi X, Chen G, Ma H et al. Attenuation of Blood-Brain barrier disruption in traumatic brain injury via Inhibition of NKCC1 cotransporter: insights into the NF-kappaB\/NLRP3 signaling pathway. J Neurotrauma. 2025.","DOI":"10.1089\/neu.2023.0580"},{"issue":"4","key":"3407_CR37","doi-asserted-by":"publisher","first-page":"C1251","DOI":"10.1152\/ajpcell.00334.2022","volume":"323","author":"R Koumangoye","year":"2022","unstructured":"Koumangoye R, Penny P, Delpire E. Loss of NKCC1 function increases epithelial tight junction permeability by upregulating claudin-2 expression. Am J Physiol Cell Physiol. 2022;323(4):C1251.","journal-title":"Am J Physiol Cell Physiol"},{"issue":"1","key":"3407_CR38","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/s41467-019-13851-6","volume":"11","author":"J Zhang","year":"2020","unstructured":"Zhang J, Bhuiyan MIH, Zhang T, Karimy JK, Wu Z, Fiesler VM, et al. Modulation of brain cation-Cl(-) cotransport via the SPAK kinase inhibitor ZT-1a. Nat Commun. 2020;11(1):78.","journal-title":"Nat Commun"},{"issue":"2","key":"3407_CR39","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/s00701-021-05088-4","volume":"164","author":"T Metayer","year":"2022","unstructured":"Metayer T, Orset C, Ali C, Furon J, Szabla N, Emery E, et al. Bumetanide lowers acute hydrocephalus in a rat model of subarachnoid hemorrhage. Acta Neurochir (Wien). 2022;164(2):499.","journal-title":"Acta Neurochir (Wien)"},{"key":"3407_CR40","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.ejphar.2015.12.001","volume":"770","author":"MD Donovan","year":"2016","unstructured":"Donovan MD, Schellekens H, Boylan GB, Cryan JF, Griffin BT. In vitro bidirectional permeability studies identify Pharmacokinetic limitations of NKCC1 inhibitor bumetanide. Eur J Pharmacol. 2016;770:117.","journal-title":"Eur J Pharmacol"},{"key":"3407_CR41","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.neuint.2017.05.020","volume":"111","author":"J Zhang","year":"2017","unstructured":"Zhang J, Pu H, Zhang H, Wei Z, Jiang X, Xu M, et al. Inhibition of Na(+)-K(+)-2Cl(-) cotransporter attenuates blood-brain-barrier disruption in a mouse model of traumatic brain injury. Neurochem Int. 2017;111:23.","journal-title":"Neurochem Int"},{"issue":"3","key":"3407_CR42","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s11481-023-10080-z","volume":"18","author":"DS Peres","year":"2023","unstructured":"Peres DS, Viero FT, Rodrigues P, de Barros Bernardes L, da Silva NAR, Lima IR, et al. Characterization of Depression- and Anxiety-Like behaviours in a mouse model of Relapsing-Remitting multiple sclerosis. J Neuroimmune Pharmacol. 2023;18(3):235.","journal-title":"J Neuroimmune Pharmacol"},{"key":"3407_CR43","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.jaut.2013.06.008","volume":"45","author":"M Rangachari","year":"2013","unstructured":"Rangachari M, Kuchroo VK. Using EAE to better understand principles of immune function and autoimmune pathology. J Autoimmun. 2013;45:31.","journal-title":"J Autoimmun"},{"issue":"47","key":"3407_CR44","doi-asserted-by":"publisher","first-page":"e2300733120","DOI":"10.1073\/pnas.2300733120","volume":"120","author":"AS Thomann","year":"2023","unstructured":"Thomann AS, McQuade CA, Pinjusic K, Kolz A, Schmitz R, Kitamura D, et al. A B cell-driven EAE mouse model reveals the impact of B cell-derived cytokines on CNS autoimmunity. Proc Natl Acad Sci U S A. 2023;120(47):e2300733120.","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-025-03407-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12974-025-03407-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-025-03407-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T11:38:39Z","timestamp":1741865919000},"score":1,"resource":{"primary":{"URL":"https:\/\/jneuroinflammation.biomedcentral.com\/articles\/10.1186\/s12974-025-03407-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,13]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3407"],"URL":"https:\/\/doi.org\/10.1186\/s12974-025-03407-5","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,13]]},"assertion":[{"value":"25 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study (ethics protocol number: HT-2024-LWFB-0022) was approved by the Animal Care and Use Committee of Zhejiang Huitong Test & Evaluation Technology Group.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"80"}}